MS
Mayukh Sukhatme
President & CIODirector

Mayukh Sukhatme insider trades: Roivant Sciences (ROIV) stock sales

President & CIO, Roivant Sciences Last trade Aug 21, 2026 21 Form 4 filings
$109.1M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mayukh reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 21, 2026ROIV↓ Sell$12.4M
Aug 18, 2026ROIV↓ Sell$24.2M
Jun 26, 2026ROIV↓ Sell$34.1M
Feb 9, 2026ROIV↓ Sell$9.0M
Dec 31, 2025ROIV↓ Sell$28.9M
Dec 17, 2025ROIV↓ Sell$620K
Dec 26, 2024ROIV↓ Sell$10.6M
Dec 18, 2024ROIV↓ Sell$5.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ROIV insiders

Open-market trades in the last 12 months

About Mayukh Sukhatme's insider trades

Mayukh Sukhatme is President & CIO at Roivant Sciences (ROIV). Since Dec 18, 2024, Mayukh has reported no open-market purchases and 8 sales worth $124.7M on SEC Form 4. In the last 12 months: 6 sales ($109.1M).

Their filings also include option exercises (15 filings), shares withheld for taxes (5 filings), other transactions (4 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.